Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Direct Compression
Lubricants & Glidants
Co-Processed Excipients
Granulation
Taste Masking
Disintegrants & Superdisintegrants
Thickeners and Stabilizers
Controlled & Modified Release
Coating Systems & Additives
Emulsifying Agents
Chewable & Orodispersible Aids
Surfactant & Foaming Agents
API Stability Enhancers
Topical
Digital Content
NEWS #PharmaBuzz
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Quazepam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Quazepam, including repackagers and relabelers. The FDA regulates Quazepam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Quazepam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Quazepam supplier is an individual or a company that provides Quazepam active pharmaceutical ingredient (API) or Quazepam finished formulations upon request. The Quazepam suppliers may include Quazepam API manufacturers, exporters, distributors and traders.
click here to find a list of Quazepam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Quazepam DMF (Drug Master File) is a document detailing the whole manufacturing process of Quazepam active pharmaceutical ingredient (API) in detail. Different forms of Quazepam DMFs exist exist since differing nations have different regulations, such as Quazepam USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Quazepam DMF submitted to regulatory agencies in the US is known as a USDMF. Quazepam USDMF includes data on Quazepam's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Quazepam USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Quazepam suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Quazepam Drug Master File in Japan (Quazepam JDMF) empowers Quazepam API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Quazepam JDMF during the approval evaluation for pharmaceutical products. At the time of Quazepam JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Quazepam suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Quazepam as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Quazepam API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Quazepam as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Quazepam and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Quazepam NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Quazepam suppliers with NDC on PharmaCompass.
Quazepam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Quazepam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Quazepam GMP manufacturer or Quazepam GMP API supplier for your needs.
A Quazepam CoA (Certificate of Analysis) is a formal document that attests to Quazepam's compliance with Quazepam specifications and serves as a tool for batch-level quality control.
Quazepam CoA mostly includes findings from lab analyses of a specific batch. For each Quazepam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Quazepam may be tested according to a variety of international standards, such as European Pharmacopoeia (Quazepam EP), Quazepam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Quazepam USP).
LOOKING FOR A SUPPLIER?
